Mosaic Variegated Aneuploidy Syndrome 4 C5774267
A chromosome instability disorder where cells have abnormal numbers of chromosomes. It can cause developmental delays and raise cancer risk. Treatment involves regular monitoring for tumors and supportive therapies.
Key facts at a glance
- ICD-10
- Q89.9
- ICD-11
- LA00.0
- Body system
- congenital
- Severity
- severe
- Chronic
- true
Signs and symptoms
Common signs and symptoms that may indicate this condition.
Warning signs - seek immediate care
Seizures
Generalized symptoms
(congenital)Significant symptoms that substantially affect daily functioning.
Frequency: Common at all stages
Severe developmental delay
(neurological)Congenital heart defect
(cardiovascular)Renal anomaly
(genitourinary)Diagnosis and tests
How this condition is diagnosed and what test results mean.
Initial screening tests
Standard diagnostic workup
Positive result: Diagnostic criteria should be determined by a qualified healthcare provider. [Content pending medical review.]
Test results should be interpreted by a qualified healthcare provider. [Content pending medical review.]
Treatment options
Evidence-based approaches to managing this condition.
First-line treatments
Growth and Endocrine Monitoring
Comprehensive endocrine evaluation to assess growth hormone status, thyroid function, and puberty development. Regular growth charting allows for early identification of endocrine abnormalities requiring intervention.
Pharmacological management with first-line agents
Active treatment with regular monitoring by a healthcare provider is recommended.
Seizure Management Protocol
Systematic approach to seizure evaluation and management with appropriate anticonvulsant therapy. Regular follow-up ensures optimal seizure control while minimizing medication side effects.
Additional treatment options
Motor Development Program
Specialized physical therapy focusing on motor skill development, balance training, and functional mobility. Programs adapt as patients age and their needs evolve.
physical_therapyCancer Screening Protocol
Age-appropriate malignancy surveillance including regular physical examinations, imaging studies, and laboratory markers as indicated. Enhanced screening protocols account for the increased cancer predisposition.
monitoringDevelopmental and Behavioral Support
Comprehensive psychological services including behavioral intervention, social skills training, and family education. Addresses the cognitive and adaptive challenges common in this population.
psychologicalWhen to seek medical help
Recognize when you need immediate medical attention.
See a doctor within 24 hours
Moderate to severe symptoms that may indicate worsening of this condition. Prompt medical evaluation is recommended.
Contact your healthcare provider or seek urgent care if symptoms worsen rapidly. Go to the emergency department for life-threatening symptoms.
Frequently asked questions
Common questions about this topic.
What is Mosaic Variegated Aneuploidy Syndrome 4 C5774267?
Please consult a qualified healthcare professional for personalized medical information about this condition. [Content pending medical review.]
generalMedication Comparisons
Compare medications used to treat Mosaic Variegated Aneuploidy Syndrome 4 C5774267. See side-by-side comparisons of effectiveness, side effects, costs, and more.
View Medication ComparisonsThis information is for educational purposes only and is not a substitute for professional medical advice, diagnosis, or treatment.
This content is for general informational and educational purposes only and is not a substitute for professional medical advice, diagnosis, or treatment. Always seek the guidance of a qualified healthcare provider with any questions you have about a medical condition, and never disregard professional medical advice or delay seeking it because of something you read here.
If you think you may have a medical emergency, call your local emergency number or go to the nearest emergency department immediately.
Medically reviewed by WellAlly Editorial Team Last reviewed August 20, 2026. · Read our editorial policy